43T Stock Overview
Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Tabula Rasa HealthCare, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$9.60 |
| 52 Week High | US$9.85 |
| 52 Week Low | US$3.12 |
| Beta | 1.58 |
| 1 Month Change | -0.52% |
| 3 Month Change | 36.17% |
| 1 Year Change | 177.46% |
| 3 Year Change | -66.20% |
| 5 Year Change | -85.54% |
| Change since IPO | -22.79% |
Recent News & Updates
Recent updates
Shareholder Returns
| 43T | DE Healthcare Services | DE Market | |
|---|---|---|---|
| 7D | -0.5% | -5.0% | -1.7% |
| 1Y | 177.5% | -25.1% | -0.2% |
Return vs Industry: 43T exceeded the German Healthcare Services industry which returned -10.2% over the past year.
Return vs Market: 43T exceeded the German Market which returned 5.9% over the past year.
Price Volatility
| 43T volatility | |
|---|---|
| 43T Average Weekly Movement | 8.4% |
| Healthcare Services Industry Average Movement | 4.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 43T's share price has been volatile over the past 3 months.
Volatility Over Time: 43T's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 1,027 | Brian Adams | www.tabularasahealthcare.com |
Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the United States. The company operates in two segments, CareVention HealthCare and MedWise HealthCare. It offers EireneRx, a cloud-based medication decision-support and e-prescribing platform to access patient medication-related information; and MedWise Risk Score, a medication risk stratification technology for identification of patients in need of clinical intervention.
Tabula Rasa HealthCare, Inc. Fundamentals Summary
| 43T fundamental statistics | |
|---|---|
| Market cap | €264.89m |
| Earnings (TTM) | -€56.95m |
| Revenue (TTM) | €315.33m |
0.8x
P/S Ratio-4.7x
P/E RatioIs 43T overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 43T income statement (TTM) | |
|---|---|
| Revenue | US$338.12m |
| Cost of Revenue | US$258.28m |
| Gross Profit | US$79.84m |
| Other Expenses | US$140.91m |
| Earnings | -US$61.07m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.26 |
| Gross Margin | 23.61% |
| Net Profit Margin | -18.06% |
| Debt/Equity Ratio | -418.7% |
How did 43T perform over the long term?
See historical performance and comparison